{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:20:37Z","timestamp":1787908837135,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-05260-3","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:04:33Z","timestamp":1787846673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of time to diabetic retinopathy in patients with type 2 diabetes mellitus: a survival analysis study"],"prefix":"10.1186","volume":"26","author":[{"given":"Zohre","family":"Foroozanfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Ghadiri-Anari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Mehrabbeik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"4","key":"5260_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2213-8587(19)30411-5","volume":"8","author":"S Vujosevic","year":"2020","unstructured":"Vujosevic S, Aldington SJ, Silva P, Hern\u00e1ndez C, Scanlon P, Peto T, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337\u201347.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"5260_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021;128(11):1580\u201391.","journal-title":"Ophthalmology"},{"issue":"11","key":"5260_CR3","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41433-024-03101-5","volume":"38","author":"K Curran","year":"2024","unstructured":"Curran K, Peto T, Jonas JB, Friedman D, Kim JE, Leasher J, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 2000 to 2020. Eye. 2024;38(11):2047\u201357.","journal-title":"Eye"},{"key":"5260_CR4","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"key":"5260_CR5","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"5260_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41572-025-00646-x","volume":"11","author":"S Sivaprasad","year":"2025","unstructured":"Sivaprasad S, Wong TY, Gardner TW, Sun JK, Bressler NM. Diabetic retinal disease. Nat Reviews Disease Primers. 2025;11(1):62.","journal-title":"Nat Reviews Disease Primers"},{"issue":"Supplement1","key":"5260_CR7","first-page":"S261","volume":"49","author":"Diabetes* ADAPPCf","year":"2025","unstructured":"Diabetes* ADAPPCf. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes\u20142026. Diabetes Care. 2025;49(Supplement1):S261\u201376.","journal-title":"Diabetes Care"},{"issue":"3","key":"5260_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556\u201364.","journal-title":"Diabetes Care"},{"issue":"1","key":"5260_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","volume":"44","author":"F Hill-Briggs","year":"2020","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258.","journal-title":"Diabetes Care"},{"issue":"11","key":"5260_CR10","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00125-022-05731-4","volume":"65","author":"C Schiborn","year":"2022","unstructured":"Schiborn C, Schulze MB. Precision prognostics for the development of complications in diabetes. Diabetologia. 2022;65(11):1867\u201382.","journal-title":"Diabetologia"},{"issue":"6","key":"5260_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3214306","volume":"51","author":"P Wang","year":"2019","unstructured":"Wang P, Li Y, Reddy CK. Machine learning for survival analysis: A survey. ACM Comput Surv (CSUR). 2019;51(6):1\u201336.","journal-title":"ACM Comput Surv (CSUR)"},{"issue":"1","key":"5260_CR12","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.chest.2020.03.015","volume":"158","author":"T Dey","year":"2020","unstructured":"Dey T, Mukherjee A, Chakraborty S. A practical overview and reporting strategies for statistical analysis of survival studies. Chest. 2020;158(1):S39\u201348.","journal-title":"Chest"},{"issue":"1","key":"5260_CR13","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1186\/s12889-022-13627-6","volume":"22","author":"R Khodakarami","year":"2022","unstructured":"Khodakarami R, Abdi Z, Ahmadnezhad E, Sheidaei A, Asadi-Lari M. Prevalence, awareness, treatment and control of diabetes among Iranian population: results of four national cross-sectional STEPwise approach to surveillance surveys. BMC Public Health. 2022;22(1):1216.","journal-title":"BMC Public Health"},{"issue":"1","key":"5260_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12889-020-8267-y","volume":"20","author":"M Mirzaei","year":"2020","unstructured":"Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20(1):166.","journal-title":"BMC Public Health"},{"issue":"13","key":"5260_CR15","first-page":"e147903","volume":"13","author":"A Mehrabbeik","year":"2024","unstructured":"Mehrabbeik A, Tofighi D, Khalilzadeh SH, Azizi R, Namiranian N, Azad F. Factors Associated with Achieving HbA1c Targets in Patients with Type 2 Diabetes. Jundishapur J Chronic Disease Care. 2024;13(13):e147903.","journal-title":"Jundishapur J Chronic Disease Care"},{"issue":"3","key":"5260_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.18502\/jovr.v14i3.4790","volume":"14","author":"GSM Nezhad","year":"2019","unstructured":"Nezhad GSM, Razeghinejad R, Janghorbani M, Mohamadian A, Jalalpour MH, Bazdar S, et al. Prevalence, incidence and ecological determinants of diabetic retinopathy in Iran: systematic review and meta-analysis. J ophthalmic Vis Res. 2019;14(3):321.","journal-title":"J ophthalmic Vis Res"},{"issue":"1","key":"5260_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/1753-0407.12205","volume":"7","author":"MH Dehghan","year":"2015","unstructured":"Dehghan MH, Katibeh M, Ahmadieh H, Nourinia R, Yaseri M. Prevalence and risk factors for diabetic retinopathy in the 40 to 80 year-old population in Yazd, Iran: the Yazd Eye Study. J Diabetes. 2015;7(1):139\u201341.","journal-title":"J Diabetes"},{"issue":"4","key":"5260_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/112067210801800412","volume":"18","author":"MR Manaviat","year":"2008","unstructured":"Manaviat MR, Rashidi M, Afkhami-Ardekani M. Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes. Eur J Ophthalmol. 2008;18(4):572\u20137.","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"5260_CR19","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/biom14121486","volume":"14","author":"AM Alshahrani","year":"2024","unstructured":"Alshahrani AM, Alshahrani AM, Al-Boqami BAH, Alqahtani AA, Alzahrani B, Bassi Y, et al. Prevalence and Predictors of Diabetic Retinopathy in Saudi Arabia: Insights from a Systematic Review and Meta-Analysis. Biomolecules. 2024;14(12):1486.","journal-title":"Biomolecules"},{"key":"5260_CR20","doi-asserted-by":"crossref","unstructured":"Huang H, Wu Y, Ye H, Li J, Chen L, Huang X. Risk prediction models for diabetic retinopathy: a systematic review. Front Endocrinol 2025;16\u20132025.","DOI":"10.3389\/fendo.2025.1556049"},{"issue":"2","key":"5260_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S2213-8587(18)30128-1","volume":"7","author":"C Sabanayagam","year":"2019","unstructured":"Sabanayagam C, Banu R, Chee ML, Lee R, Wang YX, Tan G, et al. Incidence and progression of diabetic retinopathy: a systematic review. lancet Diabetes Endocrinol. 2019;7(2):140\u20139.","journal-title":"lancet Diabetes Endocrinol"},{"issue":"1","key":"5260_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s13104-018-3660-7","volume":"11","author":"TK Azeze","year":"2018","unstructured":"Azeze TK, Sisay MM, Zeleke EG. Incidence of diabetes retinopathy and determinants of time to diabetes retinopathy among diabetes patients at Tikur Anbessa Hospital, Ethiopia: a retrospective follow up study. BMC Res Notes. 2018;11(1):542.","journal-title":"BMC Res Notes"},{"issue":"1","key":"5260_CR23","doi-asserted-by":"publisher","first-page":"e090916","DOI":"10.1136\/bmjopen-2024-090916","volume":"15","author":"T Yakob","year":"2025","unstructured":"Yakob T, Abraham A, Yakob B, Jaldo MM. Incidence of diabetic retinopathy and predictors among adult patients with diabetes in central and southern Ethiopia: a multicentre retrospective cohort study. BMJ open. 2025;15(1):e090916.","journal-title":"BMJ open"},{"issue":"2","key":"5260_CR24","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1111\/aos.14927","volume":"100","author":"PH Scanlon","year":"2022","unstructured":"Scanlon PH, Nevill CR, Stratton IM, Maruti SS, Mass\u00f3-Gonz\u00e1lez EL, Sivaprasad S, et al. Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire. Acta Ophthalmol. 2022;100(2):e560\u201370.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"5260_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12961-022-00940-0","volume":"21","author":"K Curran","year":"2023","unstructured":"Curran K, Piyasena P, Congdon N, Duke L, Malanda B, Peto T. Inclusion of diabetic retinopathy screening strategies in national-level diabetes care planning in low-and middle-income countries: a scoping review. Health Res Policy Syst. 2023;21(1):2.","journal-title":"Health Res Policy Syst"},{"issue":"1","key":"5260_CR26","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1186\/s12889-025-25543-6","volume":"25","author":"YD Lestari","year":"2025","unstructured":"Lestari YD, Sitompul R, Widyahening IS, Tahapary DL, Yusuf PA, Sasongko MB, et al. Diabetic retinopathy screening model in low and middle-income countries: a scoping review. BMC Public Health. 2025;25(1):4210.","journal-title":"BMC Public Health"},{"issue":"1","key":"5260_CR27","first-page":"1362144","volume":"2022","author":"MB Takele","year":"2022","unstructured":"Takele MB, Boneya DJ, Alemu HA, Tsegaye TB, Birhanu MY, Alemu S, et al. Retinopathy among adult diabetics and its predictors in Northwest Ethiopia. J Diabetes Res. 2022;2022(1):1362144.","journal-title":"J Diabetes Res"},{"issue":"1","key":"5260_CR28","doi-asserted-by":"publisher","first-page":"2290120","DOI":"10.1155\/2021\/2290120","volume":"2021","author":"G D\u2019Arrigo","year":"2021","unstructured":"D\u2019Arrigo G, Leonardis D, Abd ElHafeez S, Fusaro M, Tripepi G, Roumeliotis S. Methods to Analyse Time-to\u2010Event Data: The Kaplan\u2010Meier Survival Curve. Oxidative Med Cell Longev. 2021;2021(1):2290120.","journal-title":"Oxidative Med Cell Longev"},{"key":"5260_CR29","doi-asserted-by":"crossref","unstructured":"Chen N-C, Shah VN, McQueen RB. Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence From Real-World Type 1 Diabetes Care. J Clin Endocrinol Metabolism. 2025:dgaf544.","DOI":"10.1210\/clinem\/dgaf544"},{"issue":"7","key":"5260_CR30","doi-asserted-by":"publisher","first-page":"e2521150","DOI":"10.1001\/jamanetworkopen.2025.21150","volume":"8","author":"IM Kim","year":"2025","unstructured":"Kim IM, Radgoudarzi N, Chen EM, Liu J, Moussa K, Shantha JG, et al. Time to Progression to Proliferative Diabetic Retinopathy in Patients With Type 2 Diabetes. JAMA Netw Open. 2025;8(7):e2521150.","journal-title":"JAMA Netw Open"},{"issue":"23","key":"5260_CR31","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.3390\/jcm13237083","volume":"13","author":"C Hern\u00e1ndez-Teixid\u00f3","year":"2024","unstructured":"Hern\u00e1ndez-Teixid\u00f3 C, de la Barrot J, Miravet Jim\u00e9nez S, Fern\u00e1ndez-Camins B, Mauricio D, Romero Aroca P, et al. Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes: A Study Using Real-World Data. J Clin Med. 2024;13(23):7083.","journal-title":"J Clin Med"},{"issue":"7","key":"5260_CR32","doi-asserted-by":"publisher","first-page":"e0325814","DOI":"10.1371\/journal.pone.0325814","volume":"20","author":"SN Fe\u02c8li","year":"2025","unstructured":"Fe\u02c8li SN, Emamian MH, Yaseri M, Riazi-Esfahani H, Hashemi H, Fotouhi A, et al. Development and validation of prediction models for diabetic retinopathy in type 2 diabetes patients. PLoS ONE. 2025;20(7):e0325814.","journal-title":"PLoS ONE"},{"key":"5260_CR33","doi-asserted-by":"publisher","first-page":"1571576","DOI":"10.3389\/fimmu.2025.1571576","volume":"16","author":"W He","year":"2025","unstructured":"He W, Tang P, Lv H. Targeting oxidative stress in diabetic retinopathy: mechanisms, pathology, and novel treatment approaches. Front Immunol. 2025;16:1571576.","journal-title":"Front Immunol"},{"key":"5260_CR34","doi-asserted-by":"publisher","first-page":"101799","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799.","journal-title":"Redox Biol"},{"key":"5260_CR35","doi-asserted-by":"crossref","unstructured":"Leley SP, Ciulla TA, Bhatwadekar AD. Diabetic retinopathy in the aging population: a perspective of pathogenesis and treatment. Clin Interv Aging. 2021:1367\u201378.","DOI":"10.2147\/CIA.S297494"},{"key":"5260_CR36","doi-asserted-by":"crossref","unstructured":"Zhang M, Wu J, Wang Y, Wu J, Hu W, Jia H et al. Associations between blood pressure levels and diabetic retinopathy in patients with diabetes mellitus: A population-based study. Heliyon. 2023;9(6).","DOI":"10.1016\/j.heliyon.2023.e16830"},{"key":"5260_CR37","doi-asserted-by":"crossref","unstructured":"Do DV, Han G, Abariga SA, Sleilati G, Vedula SS, Hawkins BS. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Reviews. 2023(3).","DOI":"10.1002\/14651858.CD006127.pub3"},{"issue":"5","key":"5260_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.62347\/DFSZ9202","volume":"14","author":"M Noroozi","year":"2024","unstructured":"Noroozi M, Ghasemirad H, Ghaedi A, Kargar M, Alipour M, Mahmoudvand G, et al. Visit-to-visit variability of blood pressure and risk of diabetic retinopathy: a systematic review and meta-analysis. Am J Cardiovasc Dis. 2024;14(5):281.","journal-title":"Am J Cardiovasc Dis"},{"issue":"1","key":"5260_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13643-023-02321-2","volume":"12","author":"Z Li","year":"2023","unstructured":"Li Z, Yuan Y, Qi Q, Wang Q, Feng L. Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Syst reviews. 2023;12(1):148.","journal-title":"Syst reviews"},{"key":"5260_CR40","doi-asserted-by":"publisher","first-page":"1699408","DOI":"10.3389\/fmed.2025.1699408","volume":"12","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zuo M, Wang C, Zhu L. Atherogenic lipid indices and diabetic retinopathy in type 2 diabetes: a systematic review and meta-analysis. Front Med. 2025;12:1699408.","journal-title":"Front Med"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05260-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:41:04Z","timestamp":1787906464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05260-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5260"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05260-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Shahid Sadoughi University of Medical Sciences, Yazd, Iran (Approval No. IR.SSU.REC.1404.021). Patient confidentiality was strictly maintained, and all data were anonymized prior to analysis. As this was a retrospective study using existing medical records, the requirement for informed consent was waived by the Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"528"}}